Product Code: RP-ID-10336538 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10336538
Market Overview:
Global Immunoprotein Diagnostic Testing Market Size study, by Type (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test and Free Light Chain Diagnostic Test), by Application (Autoimmune Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing and Toxicology Testing), by Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophores
Global Immunoprotein Diagnostic Testing Market is valued approximately at USD 10.1 billion in 2019 and is anticipated to grow with a growth rate of more than 6.6% over the forecast period 2020-2027. Immunoprotein diagnostic testing detects the level of immunoproteins in the body such as, pre-albumin, immunoglobulin, among others. With the growing incidences & prevalence of infectious and chronic diseases such as diabetes, heart disease, arthritis, kidney disease etc., rise in geriatric population, and growth in demand for early diagnostic services is likely to propel the immunoprotein diagnostic testing market. For instance: according to AgeingAsia.org, the number of people aged 60 and above were 11,988,000 in 2019 and is expected to rise by 29,841,000 in 2050. Also, the total percentage of population aged 60 and above were 12.3% in 2019 and is expected to rise by 27.2 % in 2050. Also, as per Statista, the American geriatric population (65 years old or more) was 16% in 2018 and is anticipated to rise by 22% of American geriatric population in 2050. Also, the global adult population suffered from diabetes in 2019 was around 9.3% and is expected to rise by 11% in 2045. Also, according to the United Nations, Department of Economic & Social Affairs, there were 703 million persons aged 65 years or over in the world in 2019 and is projected to double to 1.5 billion in 2050. Whereas, stringent regulations are the major factor restraining the growth of global Immunoprotein Diagnostic Testing market during the forecast period.
The regional analysis of global Immunoprotein Diagnostic Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increase in demand for quick diagnostic services to detect chronic diseases, ongoing trend of preventive healthcare, and rise in the number of drug abuse and allergy cases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.
Major market player included in this report are:
Abbott Laboratories
Abcam PLC
Bio-Rad Laboratories
Danaher Corporation
Diasorin, Enzo Life Sciences
Ortho Clinical Diagnostics
Roche Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
by Type:
C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Pre-albumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test
by Application:
Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing
By Technology:
Radioimmunoassay
Immunoturbidity Assay
Immunoprotein Electrophoresis
Enzyme-linked immunosorbent assay
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Immunoprotein Diagnostic Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Abbott Laboratories
Abcam PLC
Bio-Rad Laboratories
Danaher Corporation
Diasorin, Enzo Life Sciences
Ortho Clinical Diagnostics
Roche Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
Related Reports
Proof of Quality & Reliability
